Li Dean Y's Form 4 filing
Merck & Co., Inc. (MRK) · filed Feb 12, 2024
- Accession no.
- 0001127602-24-004438
- Filed
- Feb 12, 2024
- Trade date
- Feb 9, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.85M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Li Dean YCIK 0001837016 | Officer (Executive VP & President, MRL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2024 | Common Stock | MOption exerciseAcquired | +14,702 | $62.07 | +$912,553.14 | 60,944.37 | Direct | |
| Feb 9, 2024 | Common Stock | SSaleDisposed | −14,702 | $125.50 | −$1,845,101 | 46,242.37 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2024 | Common Stock | MOption exerciseDisposed | −14,702 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.